Viatris (VTRS): Agrees to buy Pacira BioSciences for $1.65 billion in cash
Viatris agreed to buy Pacira for $36.50 a share in cash, about $1.65B, adding non-opioid pain drugs Exparel and Zilretta. Pacira jumped roughly 44%…
Viatris (VTRS)
1 take
All Centiview takes on Viatris (ticker VTRS): earnings, deals and market news, newest first. Filed under Healthcare; region: US. Each take lists its sources. For information only, not advice.